Alzheimer Disease
Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease
Published in Genetics and Environmental Business Week, July 30th, 2009
Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced further evidence for genetic interactions impacting the efficacy of the ketogenic compound AC-1202 (Axona(TM)) in Alzheimer's disease. New data from the company's previously completed double-blind, placebo-controlled trial in patients with mild-to-moderate Alzheimer's disease demonstrates an interaction between two genetic markers that strongly influence the therapeutic response in patients. Dr. Samuel Henderson, Executive Director of Research, will present these results at the 2009 International Conference on Alzheimer's Disease (ICAD) sponsored by the Alzheimer's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Acne Vulgaris
DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology - Alzheimer Disease
Caffeine reverses memory impairment in Alzheimers mice - Alzheimer Disease
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease - Alzheimer's Association
Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimer's Clinical Studies - Antibody Engineering
Researchers' work from Biogen Idec, Inc. focuses on antibody engineering - Atrial Fibrillation
deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
